Next Article in Journal
The Roles of Microbial Cell-Cell Chemical Communication Systems in the Modulation of Antimicrobial Resistance
Next Article in Special Issue
Candida auris Urinary Tract Infections and Possible Treatment
Previous Article in Journal
Combination Therapy with Aminoglycoside in Bacteremiasdue to ESBL-Producing Enterobacteriaceae in ICU
Previous Article in Special Issue
A Cluster of Candida auris Blood Stream Infections in a Tertiary Care Hospital in Oman from 2016 to 2019
Review

Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen

1
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialities, University of Palermo, 90127 Palermo, Italy
2
Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo. Department of Anesthesia Intensive Care and Emergency, Policlinico “Paolo Giaccone”, 90127 Palermo, Italy
3
Laboratory of Microbiology, Azienda Ospedaliera Ospedali Riuniti “Villa Sofia-V. Cervello”, 90127 Palermo, Italy
4
U.O.C. of Microbiology, Virology and Parassitology, A.O.U.P. “Paolo Giaccone”, 90127 Palermo, Italy
*
Author to whom correspondence should be addressed.
Antibiotics 2020, 9(11), 778; https://doi.org/10.3390/antibiotics9110778
Received: 30 September 2020 / Revised: 27 October 2020 / Accepted: 29 October 2020 / Published: 5 November 2020
(This article belongs to the Special Issue Diagnosis,Resistance and Treatment of Infections by Candida auris)
The multidrug-resistant yeast Candida auris is associated with invasive infections in critically ill patients and has been isolated in different countries worldwide. Ease of spread, prolonged persistence in the environment and antifungal drug resistance pose a significant concern for the prevention of transmission and management of patients with C. auris infections. Early and correct identification of patients colonized with C. auris is critical in containing its spread. However, this may be complicated by C. auris strains being misidentified as other phylogenetically related pathogens. In this review, we offer a brief overview highlighting some of the critical aspects of sample collection, laboratory culture-dependent and independent identification and the susceptibility profile of C. auris. View Full-Text
Keywords: Candida auris; Candida auris identification; screening; antifungal resistance testing Candida auris; Candida auris identification; screening; antifungal resistance testing
Show Figures

Figure 1

MDPI and ACS Style

Fasciana, T.; Cortegiani, A.; Ippolito, M.; Giarratano, A.; Di Quattro, O.; Lipari, D.; Graceffa, D.; Giammanco, A. Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen. Antibiotics 2020, 9, 778. https://doi.org/10.3390/antibiotics9110778

AMA Style

Fasciana T, Cortegiani A, Ippolito M, Giarratano A, Di Quattro O, Lipari D, Graceffa D, Giammanco A. Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen. Antibiotics. 2020; 9(11):778. https://doi.org/10.3390/antibiotics9110778

Chicago/Turabian Style

Fasciana, Teresa, Andrea Cortegiani, Mariachiara Ippolito, Antonino Giarratano, Orazia Di Quattro, Dario Lipari, Domenico Graceffa, and Anna Giammanco. 2020. "Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen" Antibiotics 9, no. 11: 778. https://doi.org/10.3390/antibiotics9110778

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop